| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Immuneering Corp | Director | Class A Common Stock | 476,615 | $2,955,013 | $6.20 | 12 Jan 2026 | General Partner of PEF LLC. |
| Immuneering Corp | Director | Class A Common Stock | 392,242 | $2,431,900 | $6.20 | 12 Jan 2026 | General Partner of PF Associates L.P. |
| Immuneering Corp | Director | Class A Common Stock | 156,766 | $971,949 | $6.20 | 12 Jan 2026 | Direct |
| Immuneering Corp | Director | Class A Common Stock | 135,441 | $588,518 | $4.35 | 12 Jan 2026 | General Partner of S4K Investments LLC. |
| Notable Labs, Ltd. | Director | Ordinary Shares | 40,247 | 08 May 2024 | Direct | ||
| Notable Labs, Ltd. | Director | Stock Option | 9,753 | 24 Jan 2024 | Direct | ||
| Immuneering Corp | Director | Stock Option | 7,888 | 01 Jan 2026 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| IMRX | Immuneering Corp | 12 Jan 2026 | 1 | +$86,904 | 4 | Director | 14 Jan 2026, 08:10 |
| IMRX | Immuneering Corp | 01 Jan 2026 | 1 | $0 | 4 | Director | 02 Jan 2026, 16:50 |
| IMRX | Immuneering Corp | 03 Oct 2025 | 1 | +$50,025 | 4 | Director | 07 Oct 2025, 08:56 |
| IMRX | Immuneering Corp | 30 Sep 2025 | 1 | +$52,730 | 4 | Director | 01 Oct 2025, 08:59 |
| IMRX | Immuneering Corp | 29 Sep 2025 | 1 | +$35,900 | 4 | Director | 30 Sep 2025, 09:00 |
| IMRX | Immuneering Corp | 18 Jun 2025 | 1 | +$63,188 | 4 | Director | 23 Jun 2025, 09:09 |
| IMRX | Immuneering Corp | 13 Jun 2025 | 1 | $0 | 4 | Director | 16 Jun 2025, 09:04 |
| IMRX | Immuneering Corp | 01 Jan 2025 | 1 | $0 | 4 | Director | 02 Jan 2025, 16:12 |
| IMRX | Immuneering Corp | 12 Jun 2024 | 1 | $0 | 4 | Director | 13 Jun 2024, 16:20 |
| /report/000106299324009929-feinberg-peter-2024-05-08 | Notable Labs, Ltd. | 08 May 2024 | 1 | $0 | 4 | Director | 10 May 2024, 17:06 |
| IMRX | Immuneering Corp | 22 Mar 2024 | 1 | +$63,712 | 4 | Director | 25 Mar 2024, 09:13 |
| IMRX | Immuneering Corp | 18 Mar 2024 | 3 | +$183,058 | 4 | Director | 19 Mar 2024, 19:04 |
| /report/000106299324001366-feinberg-peter-2024-01-24 | Notable Labs, Ltd. | 24 Jan 2024 | 1 | $0 | 4 | Director | 26 Jan 2024, 11:05 |
| IMRX | Immuneering Corp | 01 Jan 2024 | 1 | $0 | 4 | Director | 02 Jan 2024, 16:26 |
| /report/000106299323019510-feinberg-peter-2023-10-16 | Notable Labs, Ltd. | 16 Oct 2023 | 0 | $0 | 3 | Director | 18 Oct 2023, 08:35 |
| IMRX | Immuneering Corp | 14 Jun 2023 | 1 | $0 | 4 | Director | 15 Jun 2023, 16:35 |
| IMRX | Immuneering Corp | 21 Jun 2022 | 1 | $0 | 4 | Director | 23 Jun 2022, 17:06 |
| IMRX | Immuneering Corp | 15 Mar 2022 | 1 | +$45,002 | 4 | Director | 16 Mar 2022, 17:30 |
| IMRX | Immuneering Corp | 20 Sep 2021 | 1 | +$116,114 | 4 | Director | 21 Sep 2021, 17:53 |
| IMRX | Immuneering Corp | 13 Sep 2021 | 2 | +$131,114 | 4 | Director | 15 Sep 2021, 17:58 |
| IMRX | Immuneering Corp | 03 Aug 2021 | 12 | +$4,375,005 | 4 | Director | 04 Aug 2021, 06:06 |
| IMRX | Immuneering Corp | 29 Jul 2021 | 0 | $0 | 3/A | Director | 13 Sep 2021, 16:31 |